从新版《药品注册管理办法》看我国药品优先审评审批制度的变化
Insights into Changes to the Priority Review System from the Perspective of the New Provisions for Drug Registration in China
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|